Carclo plc (CCEGF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Carclo plc (CCEGF) trades at $0.67 with AI Score 46/100 (Grade C). Carclo plc is a UK-based manufacturer of highly precise, injection-molded plastic components for medical, optical, diagnostics, and electronics industries, alongside specialized aerospace elements. Market cap: $49.19M, Sector: Consumer cyclical.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for CCEGF: CCEGF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CCEGF against Consumer Cyclical peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CCEGF: the 1 perspectives are evenly split.
How is this calculated? →Carclo plc (CCEGF) Consumer Business Overview
Carclo plc specializes in high-precision injection-molded plastic components for critical applications in medical, optical, diagnostics, and electronics sectors, complemented by specialized aerospace parts. Operating across global markets, the company leverages its technical expertise to serve both commercial and military clients with intricately engineered solutions.
What Is the Investment Thesis for CCEGF?
Carclo plc presents an investment profile centered on its specialized manufacturing capabilities and exposure to high-growth, high-margin sectors. With a market capitalization of $49.19M and a P/E ratio of 14.1, the company demonstrates profitability, evidenced by a 1.6% profit margin and a robust 56.8% gross margin, indicating strong control over production costs. A key value driver is the company's Technical Plastics division, which serves the medical, optical, and diagnostics industries, benefiting from the ongoing demand for precision components in advanced healthcare solutions, particularly minimally invasive surgical instruments. The Aerospace division further diversifies revenue streams by supplying specialized parts to both commercial and military aviation, a sector characterized by long product cycles and high barriers to entry. Growth catalysts include expanding market penetration in North America and Asia, where demand for advanced manufacturing and medical technology is increasing. The company's beta of 0.60 suggests lower volatility compared to the broader market. However, as an OTC-listed company with a small market cap, liquidity risks are present. The ability to secure and fulfill new contracts within its specialized markets will be crucial for sustained growth and value creation.
Based on FMP financials and quantitative analysis
CCEGF Key Highlights
- Market Capitalization: $0.05 billion, reflecting a small-cap company operating in specialized manufacturing niches.
- P/E Ratio: 14.12, indicating a valuation multiple relative to earnings that suggests investor confidence in its profitability.
- Gross Margin: 56.8%, demonstrating strong cost control and pricing power within its specialized product categories.
- Profit Margin: 1.6%, showing the company's ability to convert revenue into net income after all expenses.
- Beta: 0.60, suggesting lower price volatility compared to the overall market, potentially appealing to risk-averse investors.
Who Are CCEGF's Competitors?
CCEGF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INVZ Innoviz Technologies Ltd. | $0.68 | -2.17% | $150.02M | 68 |
| HYLN Hyliion Holdings Corp. | $4.30 | -0.35% | $767.70M | 66 |
| SES SES AI Corporation | $0.88 | -0.05% | $322.33M | 62 |
| TMH Toyota Motor Corporation ADRhedged | $48.56 | +3.48% | $3.58B | 60 |
| ECX ECARX Holdings, Inc. | $1.28 | +2.40% | $428.93M | 48 |
| MNTHY Minth Group Limited | $75.48 | +8.15% | $4.37B | 49 |
| SMTOY Sumitomo Electric Industries, Ltd. | $8.04 | -2.13% | $50.20B | 49 |
| AMV Atlis Motor Vehicles, Inc. | $0.50 | -1.88% | $17.83M | 49 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CCEGF's Key Strengths?
- Specialized expertise in high-precision injection molding and aerospace component manufacturing.
- Diversified revenue streams across medical, optical, diagnostics, electronics, and aerospace sectors.
- Strong gross margin of 56.8% indicates efficient operations and pricing power.
- International presence across key global markets including North America, Europe, and Asia.
What Are CCEGF's Weaknesses?
- Relatively small market capitalization ($0.05B) compared to larger industry players.
- Low profit margin of 1.6% suggests tight net profitability despite high gross margins.
- OTC listing may limit institutional investor access and present liquidity challenges.
- Reliance on securing and fulfilling specialized contracts, which can be cyclical or project-based.
What Could Drive CCEGF Stock Higher?
- New Contract Wins in Medical Devices: Securing significant new contracts for precision components in the rapidly expanding minimally invasive surgical instruments or advanced diagnostics markets could significantly boost revenue and investor confidence.
- Aerospace Sector Recovery and Growth: Continued recovery in commercial aviation and sustained demand in military aviation will drive orders for Carclo's specialized aerospace components, positively impacting its Aerospace division's performance.
- Strategic Geographic Market Expansion: Successful execution of plans to deepen market penetration in high-growth regions like North America or Asia, or entry into new territories, could unlock substantial revenue growth.
- Product Innovation in Technical Plastics: Continuous development and introduction of new, highly specialized plastic components for emerging applications in electronics or optics could open new revenue streams and strengthen market position.
What Are the Key Risks for CCEGF?
- Negative return on equity (-17.4%) — the business is not currently generating profit on shareholder capital.
- Liquidity Constraints from OTC Listing: The company's small market capitalization ($0.05B) and OTC Other tier listing may lead to low trading volumes and wide bid-ask spreads, making it challenging for investors to efficiently buy or sell shares.
- Dependence on Specialized Contract Fulfillment: Carclo's business relies on its ability to consistently secure and successfully fulfill contracts within its specialized markets, particularly in medical and aerospace, where project delays or failures could impact profitability.
- Fluctuations in Raw Material Costs: As a manufacturer of plastic components, the company is exposed to volatility in the prices of raw materials, which could compress its 1.6% profit margin if not effectively managed through pricing adjustments or hedging.
- Competitive Pressures in Niche Markets: Despite its specialization, Carclo operates in competitive environments, and the emergence of new technologies or more cost-effective competitors could pressure its market share and profitability.
- Economic Downturn Impact on Cyclical Sectors: Although diversified, parts of Carclo's business, particularly aerospace and certain consumer cyclical aspects, could be vulnerable to broader economic downturns, impacting demand for its components.
What Are the Growth Opportunities for CCEGF?
- Expansion in Minimally Invasive Surgical Instruments Market: The global market for minimally invasive surgical instruments is projected to grow significantly, driven by patient preference for less invasive procedures, technological advancements, and an aging population. Carclo's Technical Plastics division, which produces fine tolerance injection-molded plastic parts for medical devices, is well-positioned to capitalize on this trend. By securing new contracts and expanding its product offerings in diagnostic devices and advanced surgical solutions, Carclo can increase its market share. This opportunity has an ongoing timeline, with continuous demand growth expected over the next decade.
- Increased Penetration in Global Aerospace Supply Chains: The commercial and military aviation sectors continue to demand highly specialized components for new aircraft programs, maintenance, repair, and overhaul (MRO), and defense upgrades. Carclo's Aerospace division, supplying control cables, custom-machined components, and aerofoil blading, can pursue deeper integration into existing supply chains and target emerging aerospace manufacturers. With global air travel recovering and defense spending remaining robust, there is a sustained need for high-quality, reliable parts. This growth driver offers long-term potential, spanning the next 5-10 years as new aircraft models are developed and existing fleets are maintained.
- Leveraging Advanced Diagnostics Market Growth: The diagnostics industry, particularly in areas like point-of-care testing and personalized medicine, is experiencing rapid innovation and market expansion. Carclo's capability in producing intricately engineered plastic parts for diagnostics positions it to become a preferred supplier for companies developing next-generation diagnostic devices. This involves precision components for fluidic systems, micro-optics, and sensor housings. The market for in-vitro diagnostics alone is a multi-billion dollar industry with consistent growth, offering Carclo a continuous stream of opportunities for the foreseeable future.
- Geographic Expansion in High-Growth Regions: Carclo plc currently operates in the UK, North America, the Czech Republic, China, and India. Further strategic expansion into other high-growth emerging markets, particularly in Southeast Asia and parts of Latin America, could unlock new revenue streams. These regions are experiencing increasing industrialization, healthcare infrastructure development, and growing demand for advanced manufacturing capabilities. By establishing local partnerships or expanding existing facilities, Carclo can reduce logistics costs and better serve regional clients, with a timeline of 3-7 years for significant market entry and ramp-up.
- Diversification into New Electronics Applications: Beyond its current electronics applications, Carclo could explore new niches within the broader electronics industry that require high-precision plastic components. This might include components for advanced robotics, automation systems, specialized sensors, or emerging consumer electronics where miniaturization and complex designs are paramount. The electronics market is vast and constantly evolving, offering numerous opportunities for companies with specialized manufacturing expertise. Identifying and targeting these specific high-value sub-segments could provide a new avenue for growth over the next 5 years.
What Opportunities Does CCEGF Have?
- Growing demand for minimally invasive surgical instruments and advanced diagnostic devices.
- Expansion into new applications within the broader electronics and automation industries.
- Increased penetration in emerging markets for both healthcare and aerospace components.
- Technological advancements in materials science and manufacturing processes to enhance product offerings.
What Threats Does CCEGF Face?
- Intense competition from other specialized component manufacturers.
- Fluctuations in raw material costs for plastics and metals impacting profitability.
- Economic downturns affecting demand in cyclical sectors like automotive and commercial aerospace.
- Regulatory changes in medical or aerospace industries requiring costly compliance updates.
What Are CCEGF's Competitive Advantages?
- Specialized Manufacturing Expertise: Decades of experience in fine tolerance injection molding for complex geometries and high-performance plastics.
- High Barriers to Entry: The precision required for medical and aerospace components necessitates significant capital investment, R&D, and regulatory compliance.
- Long-standing Client Relationships: Established trust and proven track record with demanding clients in critical industries.
- Global Footprint: International manufacturing and distribution capabilities allow for diversified market access and client service.
- Diverse Sector Exposure: Serving multiple high-value sectors (medical, optical, diagnostics, aerospace) reduces reliance on any single industry.
What Does CCEGF Do?
Carclo plc, established in 1924 and headquartered in Ossett, UK, has evolved into a global manufacturer and distributor of highly precise, injection-molded plastic components. The company's operations are strategically structured into three core divisions: Technical Plastics, Aerospace, and Central, enabling a focused approach to diverse high-value markets. The Technical Plastics segment is the cornerstone of Carclo's expertise, providing intricately engineered plastic parts through advanced injection molding techniques. These components are critical for applications in demanding industries such as medical devices, optical systems, diagnostics, and electronics. For instance, in the medical sector, Carclo's precision parts are integral to diagnostic devices and advanced surgical solutions, supporting the increasing demand for minimally invasive instruments. The company's commitment to fine tolerance manufacturing ensures the reliability and performance required for these sensitive applications. Concurrently, the Aerospace division plays a vital role in both commercial and military aviation sectors. This segment produces a variety of specialized elements, including control cables, custom-machined components, aerofoil blading, streamline wires, and tie rods. These components are essential for the structural integrity, control, and aerodynamic efficiency of aircraft, reflecting Carclo's capability to meet stringent aerospace industry standards. Carclo plc's international footprint extends across significant markets, including its home base in the United Kingdom, North America, the Czech Republic, China, and India. This broad geographic reach allows the company to serve a diverse client base and capitalize on regional growth opportunities within its specialized sectors. With 1059 employees, Carclo plc maintains a strong focus on engineering excellence and specialized manufacturing, positioning itself as a key supplier for high-performance component needs globally.
What Products and Services Does CCEGF Offer?
- Manufacture highly precise, injection-molded plastic components.
- Produce intricately engineered plastic parts for medical devices, optical systems, diagnostics, and electronics.
- Supply specialized elements like control cables and custom-machined components for aerospace.
- Serve both commercial and military aviation sectors with aerofoil blading, streamline wires, and tie rods.
- Operate through Technical Plastics, Aerospace, and Central divisions.
- Conduct business internationally across the UK, North America, Czech Republic, China, and India.
How Does CCEGF Make Money?
- Generate revenue through the sale of custom-engineered, high-precision plastic components and specialized aerospace parts.
- Focus on business-to-business (B2B) sales, serving other manufacturers in specialized industries.
- Leverage proprietary injection molding techniques and engineering expertise to create value-added products.
- Maintain long-term contracts and relationships with clients in demanding sectors like medical and aerospace.
What Industry Does CCEGF Operate In?
Carclo plc operates within the Consumer Cyclical sector, specifically in Auto - Parts, but its core business extends significantly into specialized industrial applications, including medical, optical, diagnostics, and aerospace. The broader market for precision injection-molded plastics is driven by technological advancements and increasing demand for miniaturization and complex geometries across various industries. In the medical sector, the market for minimally invasive surgical instruments and diagnostic devices is experiencing robust growth, fueled by an aging global population and advancements in healthcare technology. Carclo's focus on fine tolerance components positions it to capitalize on this trend. Similarly, the aerospace industry, encompassing both commercial and military segments, requires highly specialized and durable components, a niche Carclo's Aerospace division addresses. The competitive landscape includes other specialized manufacturers of plastic components and aerospace parts, often with regional focuses or specific material expertise. Carclo differentiates itself through its long-standing history (established 1924), international presence, and dedicated technical expertise in high-precision molding and specialized aerospace manufacturing, allowing it to serve demanding clients who require stringent quality and performance standards.
Who Are CCEGF's Key Customers?
- Medical device manufacturers requiring precision plastic components for diagnostic devices and surgical instruments.
- Optical system developers needing intricate plastic parts for lenses and housings.
- Electronics companies utilizing specialized plastic components for various devices.
- Commercial aviation manufacturers and MRO (Maintenance, Repair, and Overhaul) providers.
- Military aviation contractors and defense sector entities.
Company Profile
Carclo plc operates in the Auto - Parts industry within the Consumer Cyclical sector. It is headquartered in Mitcham, GB. The company is led by CEO Franciscus Lodewijk Paulus Doorenbosch. CCEGF has traded publicly since 2012.
F-Score 7/9Financial Health
Carclo plc's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.16 places it in the safe zone, indicating low near-term bankruptcy risk.
ROE -17%Key Financial Metrics
Return on equity for Carclo plc stands at -17.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.0%, showing how much profit it generates from its asset base. CCEGF trades at a trailing price-to-earnings ratio of 14.12, below the Consumer Cyclical sector average of ~39x. Its free cash flow yield is 28.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.32 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 7.4%, the inverse of the P/E and a quick read on earnings relative to price.
CCEGF Valuation & Market Position
With a $49.19M market cap, Carclo plc sits in the micro-cap segment of the market. Relative to its peer group, CCEGF's quantitative score of 46/100 is below the peer average of 61/100.
FY2026 estForward Outlook
Wall Street analysts project Carclo plc revenue of about $114.7M for fiscal 2026, with EPS near $0.04.
CCEGF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future prospects, indicating that those closest to the business see value.
- Community sentiment has turned positive, with many traders highlighting recent product innovations that could enhance market share.
- Analysts have noted a potential recovery in demand for Carclo's specialty products, aligning with broader industry trends.
- The company's commitment to sustainability initiatives has resonated well with socially-conscious investors, boosting overall sentiment.
Bear Case
- Concerns over supply chain disruptions persist, which could impact production timelines and overall profitability.
- Recent earnings reports have shown mixed results, leading some investors to question the company's growth trajectory.
- Community discussions reveal skepticism about the company's ability to scale operations efficiently in a competitive market.
- Market perception remains cautious, with some traders highlighting historical volatility in Carclo's stock performance as a red flag.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CCEGF Latest News
No recent news available for CCEGF.
CCEGF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CCEGF.
Price Targets
Wall Street price target analysis for CCEGF.
CCEGF MoonshotScore
What does this score mean?
The MoonshotScore rates CCEGF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Franciscus Lodewijk Paulus Doorenbosch
Chief Executive Officer
Franciscus Lodewijk Paulus Doorenbosch serves as the Chief Executive Officer of Carclo plc, overseeing a global workforce of 1059 employees. His career trajectory has likely involved significant leadership roles within manufacturing or engineering-focused industries, given Carclo's specialized operations in precision components. While specific educational background details are not provided, his position at the helm of a company with a near-century-long history in technical manufacturing suggests extensive experience in operational management, strategic planning, and international business development. His leadership is critical in navigating the complexities of high-precision manufacturing across diverse sectors like medical, aerospace, and electronics.
Track Record: Under Franciscus Lodewijk Paulus Doorenbosch's leadership, Carclo plc continues to focus on its core strengths in high-precision injection molding and specialized aerospace component manufacturing. His strategic decisions have likely aimed at maintaining the company's competitive edge in demanding markets, securing key contracts, and optimizing global operations across the UK, North America, Czech Republic, China, and India. His tenure has been marked by the ongoing management of a complex international business serving critical industries.
CCEGF OTC Market Information
CCEGF trades on the "OTC Other" tier, which is the lowest of the three primary OTC Markets tiers (OTCQX, OTCQB, and OTC Pink). Companies on the OTC Other tier are typically those that do not meet the disclosure or financial standards for OTCQX or OTCQB, or that choose not to provide information to OTC Markets Group. This tier includes companies that are current in their reporting with a U.S. regulator (like the SEC) or a non-U.S. regulator, as well as companies with limited or no public disclosure. Unlike stocks listed on major exchanges like NYSE or NASDAQ, which have stringent listing requirements including minimum share prices, market capitalization, and regular SEC filings, OTC Other companies face fewer regulatory hurdles for listing.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and transparency due to "Unknown" disclosure status.
- Significantly higher liquidity risk compared to exchange-listed stocks, making entry and exit difficult.
- Increased volatility due to lower trading volumes and fewer institutional participants.
- Potential for price manipulation given the less regulated environment and lower trading activity.
- Difficulty in obtaining reliable valuation metrics and comparable company data.
- Verify the company's primary listing and its reporting requirements on that exchange.
- Obtain and thoroughly review the latest available financial statements and annual reports directly from the company or its home country regulator.
- Research the company's management team and board of directors for their experience and track record.
- Analyze the company's competitive landscape and market position within its specialized niches.
- Assess the company's debt levels, cash flow, and ability to fund operations and growth initiatives.
- Investigate any recent news, press releases, or corporate actions that may impact the stock.
- Understand the regulatory environment and potential risks specific to its operating countries.
- Established in 1924, indicating a long operational history and resilience.
- International operations across multiple countries (UK, North America, Czech Republic, China, India).
- Specialization in high-precision manufacturing for critical industries like medical and aerospace.
- Publicly named CEO, Franciscus Lodewijk Paulus Doorenbosch, managing 1059 employees.
- Identified headquarters in Ossett, UK, a tangible physical presence.
Common Questions About CCEGF (Consumer Cyclical)
What does Carclo plc do?
Carclo plc is a UK-based company specializing in the design, manufacture, and distribution of highly precise, injection-molded plastic components and specialized aerospace elements. Its operations are divided into Technical Plastics and Aerospace divisions. The Technical Plastics segment serves critical industries such as medical, optical, diagnostics, and electronics, providing intricately engineered plastic parts essential for devices like minimally invasive surgical instruments and advanced diagnostic tools. The Aerospace division manufactures a range of specialized components, including control cables, custom-machined parts, and aerofoil blading, for both commercial and military aviation sectors. The company operates internationally across the United Kingdom, North America, the Czech Republic, China, and India, leveraging its expertise to meet stringent quality and performance standards.
What is CCEGF's dividend and shareholder return track record?
Based on the provided financial data, Carclo plc (CCEGF) currently does not pay a dividend, as indicated by "Dividend Yield: None (no dividend)". This suggests that the company is either reinvesting all its earnings back into the business for growth and operational improvements, or its current financial position does not support dividend payouts. For institutional investors, the absence of a dividend means that shareholder returns would primarily be driven by capital appreciation of the stock. Without a dividend history, there is no track record of dividend growth or payout ratios to analyze. Information on share buyback programs is also not provided in the source data, making it challenging to assess other forms of direct shareholder returns beyond stock performance.
How does Carclo plc manage supply chain and input cost risks?
Carclo plc operates in industries requiring high-precision components, making its supply chain management critical. While specific details on its risk mitigation strategies are not provided, the company's strong gross margin of 56.8% suggests effective cost management and potentially strong pricing power or efficient production processes. As a manufacturer of plastic components, Carclo is exposed to fluctuations in raw material costs, such as various polymers and specialized metals for its aerospace division. To manage these input cost risks, the company likely employs strategies such as long-term supplier contracts, diversification of its supplier base across different geographies, and potentially forward purchasing or hedging agreements for key materials. Its international operational footprint across multiple countries could also provide flexibility in sourcing and manufacturing, helping to mitigate regional supply chain disruptions.
What are the main risks for CCEGF?
Carclo plc faces several key risks that institutional investors may want to evaluate. A primary concern is the liquidity risk associated with its OTC Other tier listing and small market capitalization of $49.19M, which can lead to low trading volumes and wide bid-ask spreads, making transactions difficult. The company's "Unknown" disclosure status on the OTC market also presents transparency challenges. Operationally, Carclo is highly dependent on securing and fulfilling specialized contracts, particularly in the medical and aerospace sectors; any failure or delay in these projects could significantly impact revenue and profitability. Furthermore, as a manufacturer, the company is exposed to volatility in raw material costs, which could compress its relatively thin 1.6% profit margin if not effectively managed. Intense competition in its niche markets and potential economic downturns affecting demand in its cyclical sectors also pose ongoing threats to its financial performance.
What are the key factors to evaluate for CCEGF?
Carclo plc (CCEGF) holds an AI score of 46/100 (low). P/E: 14.1x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does CCEGF data refresh on this page?
CCEGF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CCEGF's recent stock price performance?
Carclo plc (CCEGF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Specialized expertise in high-precision injection molding and aerospace component manufacturing. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CCEGF overvalued or undervalued right now?
Carclo plc (CCEGF) trades at 14.1x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- FMP PEER TICKERS were not provided in the source data, so the 'competitors' array is empty.
- Specific details on CEO's tenure start date, education, and detailed career history were not provided.
- Detailed historical financial data beyond current metrics (e.g., revenue growth rates, specific profit trends) were not provided.
- Specific details on supply chain management strategies and raw material hedging were inferred based on industry practices and gross margin, as explicit details were not provided.
- No analyst ratings, price targets, or consensus information were provided in the source data.